New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Fidia Farmaceutici, SpA
http://www.fidiapharma.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Fidia Farmaceutici, SpA
Deal Watch: BMS Looks To Molecular Templates’ Engineered Toxin Bodies In Cancer
Plus recent deals involving AbbVie/Caribou, Sanofi/i2O, Merck & Co./Starpharma, Protalix/SarcoMed, Targovax/Papyrus, Medivir/Ubiquigent, Eton/Azurity
NASH Drug Development Questions? US FDA Has Many Of The Answers
From biomarkers to treatment effect size, agency officials respond to some of more than a hundred questions that poured in during a webinar on development of drugs to treat the liver disease.
Scrip Asks…What Does 2021 Hold For Biopharma? Part 4: Technology And Disease
Around 100 executives highlight the hot areas to watch on the R&D front in 2021. From cancer to CNS and from regenerative medicine to real world data, expectations are high on many fronts.
Flow Neuroscience Buys Halo To Apply Transcranial Stimulation To Depression
Flow plans to develop Halo’s transcranial direct current stimulation technology to treat depression and other mental health disorders.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Bioos
- Fidia Pharma Group
- Glaucoom
- OftaH.T. e Neoox
- Soluciones Bioregenerativas SL
- Sooft Italia
- Fidia Pharma Austria GmbH